Geller Melissa A, Argenta Peter A, Thomas Sajeena G, Dusenbery Kathryn E, Judson Patricia L, Boente Matthew P
Division of Gynecologic Oncology, University of Minnesota, Department of Obstetrics, Gynecology and Women's Health, Minneapolis, MN 55455, USA.
Eur J Obstet Gynecol Reprod Biol. 2009 Apr;143(2):93-7. doi: 10.1016/j.ejogrb.2008.12.013. Epub 2009 Feb 4.
To evaluate the feasibility and morbidity of using saline filled tissue expanders (TE) to displace the small bowel during radiation therapy in patients with gynecologic malignancies.
Ten patients undergoing surgical exploration for a gynecologic malignancy and deemed to be at high risk for the late effects of radiation therapy were consented for the possible placement of a TE. Indication for placement was need for post-operative radiation. Small bowel exclusion was reported in terms of the lowest loop identified on treatment planning film using orally ingested barium.
Small bowel loops were excluded from the pelvis to varying degrees in all patients. Lowest identifiable bowel was marked at the L4-L5 interspace in one patient, L5-S1 interspace in three patients, at or near the sacral promontory in three patients, and to the middle of S2 in one patient. In two patients the TE was removed prior to simulation. Early complications included migration of the TE during treatment, development of a vesicovaginal fistula requiring immediate removal of the TE, and enterocutaneous fistula formation in a patient who developed an abscess following treatment completion. Another patient experienced a rectovaginal fistula 18 months after removal of the TE.
TE placement can successfully isolate small bowel from the pelvis. Usage should be individualized to minimize the likelihood of short and long-term complications, particularly in patients at higher risk of morbidity.
评估在妇科恶性肿瘤患者放疗期间使用生理盐水填充组织扩张器(TE)来移位小肠的可行性和发病率。
10例因妇科恶性肿瘤接受手术探查且被认为放疗后期效应风险高的患者同意可能放置TE。放置指征为术后需要放疗。根据治疗计划片上通过口服钡剂确定的最低肠袢来报告小肠排除情况。
所有患者的小肠袢均不同程度地被排除在盆腔外。1例患者最低可识别肠袢标记在L4-L5间隙,3例患者在L5-S1间隙,3例患者在骶岬处或其附近,1例患者在S2中部。2例患者在模拟前取出了TE。早期并发症包括治疗期间TE移位、出现膀胱阴道瘘需要立即取出TE,以及1例患者在治疗完成后发生脓肿后形成肠皮肤瘘。另1例患者在取出TE 18个月后出现直肠阴道瘘。
放置TE可成功将小肠与盆腔隔离。使用应个体化,以尽量减少短期和长期并发症的可能性,特别是在发病风险较高的患者中。